Contemplate the data and tweets to guess whether the closing price of $amgn will surge or decline at 2017-03-29. Please declare either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-15,-1.3,0.9,-1.3,1.4,1.4,-1.0,-1.6,-2.3,-3.1,-4.2,-5.3
2017-03-16,0.8,1.0,-1.2,-1.4,-1.4,0.5,-0.1,-0.7,-1.5,-2.5,-3.6
2017-03-17,-0.7,1.8,-1.6,-6.4,-6.4,5.9,6.0,5.8,5.1,4.2,3.2
2017-03-20,0.2,0.3,-0.9,0.4,0.4,4.1,5.0,5.2,4.6,3.8,2.9
2017-03-21,1.9,2.0,-0.2,-1.4,-1.4,4.0,5.9,6.3,5.9,5.3,4.4
2017-03-22,0.3,0.3,-0.5,0.4,0.4,1.8,4.9,5.5,5.4,4.9,4.1
2017-03-23,0.9,1.2,-0.3,-0.8,-0.8,1.0,5.0,5.9,6.0,5.7,4.9
2017-03-24,0.6,0.7,-0.4,-0.2,-0.2,0.8,4.2,5.5,5.9,5.7,5.1
2017-03-27,-0.1,1.0,-1.2,-0.5,-0.5,0.8,3.8,5.4,6.1,6.0,5.6
2017-03-28,-0.4,0.9,-0.6,-0.1,-0.1,0.6,3.0,5.1,5.9,6.0,5.7

2017-03-15: rt AT_USER ahead of the #acc17 fourier presentation, here's an interview i did w/harvard pilgrim on repatha risk sharing. |$amgn:us mizuho analysts give amgen, inc. (amgn) a $195.00 price target #amge
2017-03-16: AT_USER $amgn news is on their cholesterol drug, re: cv benefits|rt AT_USER nice job rbc surveying 100 cardiologist on cholesterol lowering drugs   10 key takeaways $amgn $regn $mrk $espr $mdco |get t
2017-03-17: $amgn max pain is 175.00 for maturity 03/24/2017. prev close = 180.11.   |#amgen and axt slump while adobe and tiffany advance. read more:  $amgn|$amgn - amgen's repatha study shows reduced risk of he
2017-03-18: $amgn sum put vol=7,803 sum call vol=5,079 putcallratio=1.54 expiration 03/24/2017 .  |bharara was investigating hhs chief tom price - report $amgn $bmy $lly $pfe $aet  via AT_USER|u can be lay and in
2017-03-19: rt AT_USER week in review: bgi genomics plans $250 million shenzhen ipo $pfe $amgn |#amgen discounts cholesterol drug, but payers want more. read more:  $amgn|rt AT_USER $amgn says 11 million american
2017-03-20: member video: #1358 $vrx $memp $nktr $amgn nails &amp; good 'ol $espr making me try all day  |the #acc17 skinny: amgen's pcsk9 outcry, az's sglt2 death cuts, xarelto's aspirin beat  $amgn $azn|rt AT_U
2017-03-21: AT_USER yea thats a good point would need to be someone big though ie like $kite $amgn $june $celg etc|rt AT_USER just posted my thoughts on the fourier trial data with repatha:  $amgn $espr $sny $reg
2017-03-22: rt AT_USER $ibb $xbi $celg $agn $amgn $regn $gild can't stress the importance of this video enough! $study |$ibb $xbi $celg $agn $amgn $regn $gild can't stress the importance of this video enough! $st
2017-03-23: {new video} biotech analysis + trade ideas: $ibb $xbi $celg $regn $amgn $agn $gild --&gt;  |i am bearish on $amgn with a target price of $161.06 in 1 mo. on vetr! |scan results - 1,2,3 retracement bea
2017-03-24:  &lt; review of this fantastic traders teaching service!! try it for free! $lly $dgx $mrk $nvs $amgn|rt AT_USER industry and dark pool traders bearish on amgen cc AT_USER $regn $sny $amgn |president t
2017-03-25: $amgn max pain = 170.00. maturity = 03/31/2017. previous close = 165.74.   |$amgn get 14 days #free #premium access on the #1 #stock #app &amp; #trump competition:  #nyctaf #ultra2017|$amgn get 14 day
2017-03-26:  &lt; review of this fantastic traders teaching service!! try it for free! $lly $dgx $mrk $nvs $amgn|6 best stocks for value investors this week - march 26, 2017 $cvg $cvs $amgn $cvco $syke $cwb |6 be
2017-03-27: #amgen's humira biosimilar approved in europe. read more:  $amgn|amgen shakes up r&amp;d staff, 400 jobs to be cut/relocated $amgn |#amgen european commission approves amgevita  (biosimilar adalimumab
2017-03-28: rt AT_USER with trial results, should $amgn amgen reconsider its pricing for #repatha?  via AT_USER|$amgn - statement of changes in beneficial ownership (4) |$amgn - statement of changes in beneficial
Answer:
date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-15,-1.3,0.9,-1.3,1.4,1.4,-1.0,-1.6,-2.3,-3.1,-4.2,-5.3
2017-03-16,0.8,1.0,-1.2,-1.4,-1.4,0.5,-0.1,-0.7,-1.5,-2.5,-3.6
2017-03-17,-0.7,1.8,-1.6,-6.4,-6.4,5.9,6.0,5.8,5.1,4.2,3.2
2017-03-20,0.2,0.3,-0.9,0.4,0.4,4.1,5.0,5.2,4.6,3.8,2.9
2017-03-21,1.9,2.0,-0.2,-1.4,-1.4,4.0,5.9,6.3,5.9,5.3,4.4
2017-03-22,0.3,0.3,-0.5,0.4,0.4,1.8,4.9,5.5,5.4,4.9,4.1
2017-03-23,0.9,1.2,-0.3,-0.8,-0.8,1.0,5.0,5.9,6.0,5.7,4.9
2017-03-24,0.6,0.7,-0.4,-0.2,-0.2,0.8,4.2,5.5,5.9,5.7,5.1
2017-03-27,-0.1,1.0,-1.2,-0.5,-0.5,0.8,3.8,5.4,6.1,6.0,5.6
2017-03-28,-0.4,0.9,-0.6,-0.1,-0.1,0.6,3.0,5.1,5.9,6.0,5.7

2017-03-15: rt AT_USER ahead of the #acc17 fourier presentation, here's an interview i did w/harvard pilgrim on repatha risk sharing. |$amgn:us mizuho analysts give amgen, inc. (amgn) a $195.00 price target #amge
2017-03-16: AT_USER $amgn news is on their cholesterol drug, re: cv benefits|rt AT_USER nice job rbc surveying 100 cardiologist on cholesterol lowering drugs   10 key takeaways $amgn $regn $mrk $espr $mdco |get t
2017-03-17: $amgn max pain is 175.00 for maturity 03/24/2017. prev close = 180.11.   |#amgen and axt slump while adobe and tiffany advance. read more:  $amgn|$amgn - amgen's repatha study shows reduced risk of he
2017-03-18: $amgn sum put vol=7,803 sum call vol=5,079 putcallratio=1.54 expiration 03/24/2017 .  |bharara was investigating hhs chief tom price - report $amgn $bmy $lly $pfe $aet  via AT_USER|u can be lay and in
2017-03-19: rt AT_USER week in review: bgi genomics plans $250 million shenzhen ipo $pfe $amgn |#amgen discounts cholesterol drug, but payers want more. read more:  $amgn|rt AT_USER $amgn says 11 million american
2017-03-20: member video: #1358 $vrx $memp $nktr $amgn nails &amp; good 'ol $espr making me try all day  |the #acc17 skinny: amgen's pcsk9 outcry, az's sglt2 death cuts, xarelto's aspirin beat  $amgn $azn|rt AT_U
2017-03-21: AT_USER yea thats a good point would need to be someone big though ie like $kite $amgn $june $celg etc|rt AT_USER just posted my thoughts on the fourier trial data with repatha:  $amgn $espr $sny $reg
2017-03-22: rt AT_USER $ibb $xbi $celg $agn $amgn $regn $gild can't stress the importance of this video enough! $study |$ibb $xbi $celg $agn $amgn $regn $gild can't stress the importance of this video enough! $st
2017-03-23: {new video} biotech analysis + trade ideas: $ibb $xbi $celg $regn $amgn $agn $gild --&gt;  |i am bearish on $amgn with a target price of $161.06 in 1 mo. on vetr! |scan results - 1,2,3 retracement bea
2017-03-24:  &lt; review of this fantastic traders teaching service!! try it for free! $lly $dgx $mrk $nvs $amgn|rt AT_USER industry and dark pool traders bearish on amgen cc AT_USER $regn $sny $amgn |president t
2017-03-25: $amgn max pain = 170.00. maturity = 03/31/2017. previous close = 165.74.   |$amgn get 14 days #free #premium access on the #1 #stock #app &amp; #trump competition:  #nyctaf #ultra2017|$amgn get 14 day
2017-03-26:  &lt; review of this fantastic traders teaching service!! try it for free! $lly $dgx $mrk $nvs $amgn|6 best stocks for value investors this week - march 26, 2017 $cvg $cvs $amgn $cvco $syke $cwb |6 be
2017-03-27: #amgen's humira biosimilar approved in europe. read more:  $amgn|amgen shakes up r&amp;d staff, 400 jobs to be cut/relocated $amgn |#amgen european commission approves amgevita  (biosimilar adalimumab
2017-03-28: rt AT_USER with trial results, should $amgn amgen reconsider its pricing for #repatha?  via AT_USER|$amgn - statement of changes in beneficial ownership (4) |$amgn - statement of changes in beneficial